Zhejiang Jolly Pharmaceutical Co.,LTD

XSEC:300181 Stock Report

Market Cap: CN¥11.4b

Zhejiang Jolly PharmaceuticalLTD Balance Sheet Health

Financial Health criteria checks 6/6

Zhejiang Jolly PharmaceuticalLTD has a total shareholder equity of CN¥2.6B and total debt of CN¥381.6M, which brings its debt-to-equity ratio to 14.4%. Its total assets and total liabilities are CN¥3.9B and CN¥1.2B respectively. Zhejiang Jolly PharmaceuticalLTD's EBIT is CN¥592.6M making its interest coverage ratio -58.9. It has cash and short-term investments of CN¥786.3M.

Key information

14.4%

Debt to equity ratio

CN¥381.56m

Debt

Interest coverage ratio-58.9x
CashCN¥786.31m
EquityCN¥2.64b
Total liabilitiesCN¥1.23b
Total assetsCN¥3.87b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300181's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.2B).

Long Term Liabilities: 300181's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥57.1M).


Debt to Equity History and Analysis

Debt Level: 300181 has more cash than its total debt.

Reducing Debt: 300181's debt to equity ratio has reduced from 27.8% to 14.4% over the past 5 years.

Debt Coverage: 300181's debt is well covered by operating cash flow (73%).

Interest Coverage: 300181 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies